US Generic Drug Market 2017 - Teva, Mylan, Actavis, Sandoz, Sun Pharma, Par Pharmaceuticals

The US generic drug market has witnessed a steady growth in the recent years. The major factors that have added to the market growth are low investment in R&D, patent expiry of innovative drugs and cost-effectiveness of generic drugs as compared to their counterparts.

Request a free sample copy of the report: www.imarcgroup.com/request?type=report&id=567&flag=B

The latest report by IMARC Group, titled “US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the US generic drug market reached a value of nearly 4 Million prescriptions in 2016, exhibiting a CAGR of 5% during 2010-2016. Over the past several years, the United States has undergone a major transformation in the pharmaceutical sector. Nearly, 80% of the total prescription drugs in the US consist of generic drugs. They are low-cost versions of the innovator drugs with same dosage, strength, risks, effects, side-effects and intended usage. Generic drugs assure that the medicines are effective and safe for the consumers. These drugs come in different forms such as oral, nebulizer, intravenous, topical and intramuscular.

Highlights of the US generic drug market:

• Upcoming patent expiry of branded drugs is projected to boost the market growth.
• With low manufacturing costs, these drugs are comparatively cheaper than innovative drugs.
• Teva represents the leading manufacturer of generic drugs in the US.

Generic drugs can only be launched by the manufacturers once the branded drugs go off-patent. Imminent patent expiry of a huge number of blockbuster innovator drugs is expected to be one of the major factors contributing to the market growth. Moreover, generic drugs require less effort in the research & development sector, thus the cost involved in the manufacturing of these drugs are lower than the branded drugs. Owing to this, generic drugs are cheaper in comparison to their counterparts, thereby making them affordable for different income groups. This helps in reducing the healthcare expenditures of the government, patients and third-party payers. Additionally, the fact that the US pharmacists are paid incentives to prescribe cheaper generic drugs has further stimulated the market growth. Other major factors fueling the growth of the market include ageing population and prevalence of chronic diseases. According to the report, the market is anticipated to reach a value of around 5 Million prescriptions by 2022.

Read full report with TOC @ www.imarcgroup.com/us-generics-market

The US generic drug market is segmented into branded and unbranded generics. Presently, unbranded generic drugs are leading the market, holding for the majority of the total generic prescription volumes. On comparing the competitive landscape of the market, the key players found are Teva, Mylan, Actavis, Sandoz, Sun Pharma, Par Pharmaceuticals, Endo Pharmaceuticals, Lupin Pharmaceuticals, Dr Reddy’s and Hospira. Among these, Teva represents the leading generic manufacturer in the US, accounting for around a fifth of the total generic sales.

Browse related reports :
GCC Generic Drug Market: www.imarcgroup.com/gcc-generic-drug-market

US Generic Injectables Market: www.imarcgroup.com/us-generic-injectables-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.Global Cigarette Lighter Market

Contact us

IMARC Group
309 2nd St, Brooklyn, NY 11215, USAWebsite: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal

Global Cataract Surgical Devices Market 2017: Region Wise Analysis of Top Players in Market By Types and Application

The global cataract surgical devices market has witnessed a steady growth over the years. This can be accredited to the availability of a wide range of modern and innovative ophthalmic devices coupled with an ageing population.

Request sample report: http://www.imarcgroup.com/request?type=report&id=840&flag=B

The latest report by IMARC Group, titled “Cataract Surgical Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global cataract surgical devices market reached a value of nearly US$ 7 Billion in 2016. Cataract is an eye disease in which things appear blurry, hazy or less colourful, resulting in cloudy or opaque vision. It can be caused due to ageing, diabetes, smoking, trauma or prolonged exposure to sunlight. Cataract can be removed using certain surgical instruments and devices, such as ophthalmic viscoelastic devices, drapes, gloves, balanced salt solution, forceps, irrigation set, and intraocular lenses. These devices are safe and help in effectively restoring vision to the eye.

Highlights of the global cataract surgical devices market:

• Rapid increase in the prevalence of ocular disorders is the key factor driving the growth of the market.
• Intraocular lenses are the most popular product type, holding the largest share.
• North America represents the largest market, accounting for the majority of the global share.

A rise in the geriatric population worldwide in confluence with growing prevalence of ocular diseases and technological advancements in the healthcare sector represent the major factors influencing the cataract surgical devices market. On the other hand, a lack of awareness among the individuals regarding the benefits of cataract surgeries along with low healthcare insurance coverage impede the growth of the cataract surgical devices market in the emerging regions. However, the governments of numerous countries are introducing healthcare programmes to reduce the burden of cataract-related diseases on the patients, further creating profitable opportunities for the manufacturers. Owing to these factors, the global cataract surgical devices market is further expected to reach a value of around US$ 9 Billion by 2022, exhibiting a CAGR of nearly 4% during 2017-2022.

The market is segmented on the basis of product type into Intraocular Lenses (IOLs), femtosecond laser, Ophthalmic Viscoelastic Devices (OVDs), phacoemulsification equipment and others. Currently, IOLs represent the most popular product type, accounting for the majority of the market share. On the basis of application, the market is segregated in hospitals, eye care clinics, and eye treatment and surgical centres, wherein hospital accounts for the largest share. On a regional basis, North America currently accounts for the largest share. Other major regions include Europe, Asia Pacific, Latin America, and Middle East and Africa. On evaluating the competitive landscape of the market, it is found that the global players are Abbott Laboratories, Hoya Corporation, Carl Zeiss Meditec, Alcon Laboratories, Inc., and Essilor.

Read full report with TOC: http://www.imarcgroup.com/cataract-surgical-devices-market

The report by IMARC Group has examined the global cataract surgical devices market on the basis of:

Product Type:

• Intraocular Lenses (IOLs) 
• Femtosecond laser 
• Ophthalmic Viscoelastic Devices (OVDs)
• Phacoemulsification Equipment 

Application:

• Hospitals
• Eye Care Clinics
• Eye Treatment and Surgical Centres

Region:

•  North America
•  Europe
•  Asia Pacific
•  Latin America
•  Middle East and Africa

Key Players:

• Abbott Laboratories
• Hoya Corporation
• Carl Zeiss Meditec
• Alcon Laboratories, Inc
• Essilor

Browse related reports:

Eyewear Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Vision Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Sanitary Napkin Market Overview 2017, Demand by Regions, Types and Analysis of Key Players

The global sanitary napkin market has witnessed a healthy growth over the past several years. This can be accredited to growing awareness about feminine hygiene, rising incomes and product versatility.

Request sample report @ http://www.imarcgroup.com/request?type=report&id=825&flag=B

The latest report by IMARC Group titled, “Sanitary Napkin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global sanitary napkin market reached a value of around US$ 14.5 Billion in 2016. Sanitary napkin is widely used by women for menstrual management. It is a thin disposable pad made of materials such as quilted cotton fabrics and layers of super absorbent polymers and plastics. Earlier, women used home-made cotton pads to deal with menstrual blood and a very small number of women were aware about sanitary napkin. However, with rising awareness sanitary napkin has become one of the most popular feminine hygiene product. Sanitary napkins have seen a tremendous product evolution from a sanitary belt in the 20th century to today’s disposable pads.

Highlights of the global sanitary napkin market:

• Improved economic conditions have led to the availability and affordability of sanitary napkins.
• Menstrual pad is the most popular product type.
• Asia-Pacific represents the largest market, followed by Europe.

Various government and NGO entities have initiated projects to spread awareness about feminine hygiene, especially in the developing nations. This has increased the demand for sanitary napkin in these regions. In line with this, manufactures are producing low-cost products. They are also focussing on product diversification, thereby expanding the consumer-base for sanitary napkins in both the developed and developing regions. The market is also being driven by aggressive promotions and marketing strategies adapted by the major players. Increasing disposable income of consumers and organised retail market are some of the other factors leading to a rise in the demand for premium products. Owing to the aforementioned factors, the market is projected to reach a value of more than US$ 18 Billon, exhibiting a CAGR of around 4%.

The global sanitary napkin market is segmented on the basis of product type, including menstrual pad and pantyliner. Amongst these, menstrual pad dominates the market, representing the most popular type. The report has also segmented the market on the basis of distribution channel, including supermarkets and hypermarkets, pharmacies, convenience stores, etc. Region-wise, Asia-Pacific represents the largest market on account of an expanding consumer-base. Other regions include Europe, North America, Latin America, and Middle East and Africa. On evaluating the competitive landscape, it is found that Procter & Gamble, Hengan International Group Company Limited, Kimberly-Clark Corporation, Edgewell Personal Care Company and Kao Corporation are the key players operative in the market.

Read full report with TOC @ http://www.imarcgroup.com/sanitary-napkin-market

The report by IMARC Group has examined the global sanitary napkin market on the basis of:

Type:

• Menstrual Pad
• Pantyliner

Distribution Channel:

• Supermarkets and hypermarkets
• Pharmacies
• Convenience stores
• Others

Region:

• Asia-Pacific
• Europe
• North America
• Latin America
• Middle East and Africa

Key Players:

• Procter & Gamble
• Hengan International Group Company Limited
• Kimberly-Clark Corporation
• Edgewell Personal Care Company
• Kao Corporation

Browse related reports :

Bath Soap Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

Perfume Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: http://www.imarcgroup.com
Follow us on twitter: @imarcglobal